View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Technology
September 7, 1997updated 03 Sep 2016 7:09pm


By CBR Staff Writer

Misys Group Plc has extended its international reach with a $922m acquisition of Medic Computer Systems Inc, a leading supplier of application software packages to physicians’ practices and other healthcare providers in the US. The $35 a share cash deal is backed by the board of Raleigh, North Carolina-based Medic and its management team – including founders John McDonnell and Alan Winchester – will continue in the enlarged group. Medic has around 10,000 systems in operation and, in its last financial year to December 31, 1996, reported pre-tax profits of $38.9m on revenues of $191.8m. The UK-based Misys, buoyed up by consistent profits growth and a strong share price, has been on the take- over trail for some time and has already recorded 70m pounds worth of acquisitions this year before the Medic deal. Misys chairman, Kevin Lomax, said: The IT healthcare market in the US demonstrates similar characteristics to those area in which we currently operate. The acquisition represents a highly attractive investment. He expects it to be earnings neutral in the first full year.

Content from our partners
Rethinking cloud: challenging assumptions, learning lessons
DTX Manchester welcomes leading tech talent from across the region and beyond
The hidden complexities of deploying AI in your business

Websites in our network
Select and enter your corporate email address Tech Monitor's research, insight and analysis examines the frontiers of digital transformation to help tech leaders navigate the future. Our Changelog newsletter delivers our best work to your inbox every week.
  • CIO
  • CTO
  • CISO
  • CSO
  • CFO
  • CDO
  • CEO
  • Architect Founder
  • MD
  • Director
  • Manager
  • Other
Visit our privacy policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.